APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ertapenem Sodium for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Ertapenem Sodium for Injection Industry Research Report 2026

Report ID 173989340526 December 2025124 pages

Choose your research edition.

Industry ResearchErtapenem Sodium for Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ertapenem Sodium for Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Ertapenem Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ertapenem Sodium for Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ertapenem Sodium for Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ertapenem Sodium for Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Ertapenem Sodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Ertapenem Sodium for Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Ertapenem Sodium for Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Ertapenem Sodium for Injection include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Unitech Biotech, Par Pharmaceutical, NorthStar Rx and Intelicure Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Ertapenem Sodium for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Ertapenem Sodium for Injection Market by Company

Chongqing Shenghuaxi Pharmaceutical Co., Ltd.

Sichuan Pharmaceutical Preparation Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Qilu Anti Pharmaceutical Co., Ltd.

Hainan Herui Pharmaceutical Co., Ltd.

Unitech Biotech

Par Pharmaceutical

NorthStar Rx

Intelicure Lifesciences

EUGIA PHARMA INC

ACS DOBFAR SPA

Ertapenem Sodium for Injection Segment by Type

0.5g

1g

Ertapenem Sodium for Injection Segment by Application

Hospital

Clinic

Other

Ertapenem Sodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Sodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Ertapenem Sodium for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Ertapenem Sodium for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Ertapenem Sodium for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ertapenem Sodium for Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Ertapenem Sodium for Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Ertapenem Sodium for Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Ertapenem Sodium for Injection Revenue of Manufacturers (2021-2026) Table 9. Global Ertapenem Sodium for Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Ertapenem Sodium for Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Ertapenem Sodium for Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Ertapenem Sodium for Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Ertapenem Sodium for Injection, Product Type & Application Table 14. Global Ertapenem Sodium for Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Ertapenem Sodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information Table 19. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview Table 20. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 22. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments Table 23. Sichuan Pharmaceutical Preparation Co., Ltd. Company Information Table 24. Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview Table 25. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 27. Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments Table 28. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 29. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 30. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 32. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments Table 33. Qilu Anti Pharmaceutical Co., Ltd. Company Information Table 34. Qilu Anti Pharmaceutical Co., Ltd. Business Overview Table 35. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 37. Qilu Anti Pharmaceutical Co., Ltd. Recent Developments Table 38. Hainan Herui Pharmaceutical Co., Ltd. Company Information Table 39. Hainan Herui Pharmaceutical Co., Ltd. Business Overview Table 40. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 42. Hainan Herui Pharmaceutical Co., Ltd. Recent Developments Table 43. Unitech Biotech Company Information Table 44. Unitech Biotech Business Overview Table 45. Unitech Biotech Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Unitech Biotech Ertapenem Sodium for Injection Product Portfolio Table 47. Unitech Biotech Recent Developments Table 48. Par Pharmaceutical Company Information Table 49. Par Pharmaceutical Business Overview Table 50. Par Pharmaceutical Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio Table 52. Par Pharmaceutical Recent Developments Table 53. NorthStar Rx Company Information Table 54. NorthStar Rx Business Overview Table 55. NorthStar Rx Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. NorthStar Rx Ertapenem Sodium for Injection Product Portfolio Table 57. NorthStar Rx Recent Developments Table 58. Intelicure Lifesciences Company Information Table 59. Intelicure Lifesciences Business Overview Table 60. Intelicure Lifesciences Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio Table 62. Intelicure Lifesciences Recent Developments Table 63. EUGIA PHARMA INC Company Information Table 64. EUGIA PHARMA INC Business Overview Table 65. EUGIA PHARMA INC Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio Table 67. EUGIA PHARMA INC Recent Developments Table 68. ACS DOBFAR SPA Company Information Table 69. ACS DOBFAR SPA Business Overview Table 70. ACS DOBFAR SPA Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio Table 72. ACS DOBFAR SPA Recent Developments Table 73. Global Ertapenem Sodium for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Ertapenem Sodium for Injection Sales by Region (2021-2026) & (K Units) Table 75. Global Ertapenem Sodium for Injection Sales Market Share by Region (2021-2026) Table 76. Global Ertapenem Sodium for Injection Sales by Region (2027-2032) & (K Units) Table 77. Global Ertapenem Sodium for Injection Sales Market Share by Region (2027-2032) Table 78. Global Ertapenem Sodium for Injection Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2026) Table 80. Global Ertapenem Sodium for Injection Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2027-2032) Table 82. North America Ertapenem Sodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 84. North America Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 85. North America Ertapenem Sodium for Injection Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Ertapenem Sodium for Injection Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Ertapenem Sodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 89. Europe Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 90. Europe Ertapenem Sodium for Injection Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Ertapenem Sodium for Injection Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Ertapenem Sodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Ertapenem Sodium for Injection Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Ertapenem Sodium for Injection Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Ertapenem Sodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 99. South America Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 100. South America Ertapenem Sodium for Injection Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Ertapenem Sodium for Injection Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Ertapenem Sodium for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Ertapenem Sodium for Injection Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Ertapenem Sodium for Injection Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 108. Global Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 109. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026) Table 110. Global Ertapenem Sodium for Injection Sales Market Share by Type (2027-2032) Table 111. Global Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2026) Table 114. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2027-2032) Table 115. Global Ertapenem Sodium for Injection Price by Type (2021-2026) & (US$/Unit) Table 116. Global Ertapenem Sodium for Injection Price by Type (2027-2032) & (US$/Unit) Table 117. Global Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 118. Global Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 119. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026) Table 120. Global Ertapenem Sodium for Injection Sales Market Share by Application (2027-2032) Table 121. Global Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2026) Table 124. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2027-2032) Table 125. Global Ertapenem Sodium for Injection Price by Application (2021-2026) & (US$/Unit) Table 126. Global Ertapenem Sodium for Injection Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Ertapenem Sodium for Injection Distributors List Table 130. Ertapenem Sodium for Injection Customers List Table 131. Ertapenem Sodium for Injection Industry Trends Table 132. Ertapenem Sodium for Injection Industry Drivers Table 133. Ertapenem Sodium for Injection Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Ertapenem Sodium for Injection Product Image Figure 5. Global Ertapenem Sodium for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Ertapenem Sodium for Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Ertapenem Sodium for Injection Sales (2021-2032) & (K Units) Figure 8. Global Ertapenem Sodium for Injection Average Price (US$/Unit) & (2021-2032) Figure 9. 0.5g Product Image Figure 10. 1g Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Ertapenem Sodium for Injection Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Ertapenem Sodium for Injection, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Ertapenem Sodium for Injection Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Ertapenem Sodium for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Ertapenem Sodium for Injection Sales by Region in 2025 Figure 20. Global Ertapenem Sodium for Injection Revenue by Region in 2025 Figure 21. North America Ertapenem Sodium for Injection Market Size by Country in 2025 Figure 22. North America Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 23. North America Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2032) Figure 24. United States Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Ertapenem Sodium for Injection Market Size by Country in 2025 Figure 28. Europe Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Ertapenem Sodium for Injection Market Size by Country in 2025 Figure 41. Asia Pacific Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2032) Figure 43. China Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Ertapenem Sodium for Injection Market Size by Country in 2025 Figure 52. South America Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 53. South America Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2032) Figure 54. Brazil Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Ertapenem Sodium for Injection Market Size by Country in 2025 Figure 59. Middle East and Africa Ertapenem Sodium for Injection Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Ertapenem Sodium for Injection Revenue Market Share by Country (2021-2032) Figure 61. Egypt Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Ertapenem Sodium for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2032) Figure 67. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2032) Figure 68. Global Ertapenem Sodium for Injection Price (US$/Unit) by Type (2021-2032) Figure 69. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2032) Figure 70. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2032) Figure 71. Global Ertapenem Sodium for Injection Price (US$/Unit) by Application (2021-2032) Figure 72. Ertapenem Sodium for Injection Value Chain Figure 73. Ertapenem Sodium for Injection Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Ertapenem Sodium for Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  • Sichuan Pharmaceutical Preparation Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Qilu Anti Pharmaceutical Co., Ltd.
  • Hainan Herui Pharmaceutical Co., Ltd.
  • Unitech Biotech
  • Par Pharmaceutical
  • NorthStar Rx
  • Intelicure Lifesciences
  • EUGIA PHARMA INC
  • ACS DOBFAR SPA

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Ertapenem Sodium for Injection Market Size (2021-2032)
  4. 2.2.2 Global Ertapenem Sodium for Injection Sales (2021-2032)
  5. 2.2.3 Global Ertapenem Sodium for Injection Market Average Price (2021-2032)
  6. 2.3 Ertapenem Sodium for Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 0.5g
  9. 2.3.3 1g
  10. 2.4 Ertapenem Sodium for Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Ertapenem Sodium for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Ertapenem Sodium for Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Ertapenem Sodium for Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Ertapenem Sodium for Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Ertapenem Sodium for Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Ertapenem Sodium for Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Ertapenem Sodium for Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Ertapenem Sodium for Injection, Established Date
  9. 3.9 Global Ertapenem Sodium for Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  2. 4.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  6. 4.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Sichuan Pharmaceutical Preparation Co., Ltd.
  8. 4.2.1 Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
  9. 4.2.2 Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview
  10. 4.2.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  12. 4.2.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments
  13. 4.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  14. 4.3.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  18. 4.3.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Qilu Anti Pharmaceutical Co., Ltd.
  20. 4.4.1 Qilu Anti Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Qilu Anti Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  24. 4.4.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Hainan Herui Pharmaceutical Co., Ltd.
  26. 4.5.1 Hainan Herui Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Hainan Herui Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  30. 4.5.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Unitech Biotech
  32. 4.6.1 Unitech Biotech Company Information
  33. 4.6.2 Unitech Biotech Business Overview
  34. 4.6.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
  36. 4.6.5 Unitech Biotech Recent Developments
  37. 4.7 Par Pharmaceutical
  38. 4.7.1 Par Pharmaceutical Company Information
  39. 4.7.2 Par Pharmaceutical Business Overview
  40. 4.7.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
  42. 4.7.5 Par Pharmaceutical Recent Developments
  43. 4.8 NorthStar Rx
  44. 4.8.1 NorthStar Rx Company Information
  45. 4.8.2 NorthStar Rx Business Overview
  46. 4.8.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
  48. 4.8.5 NorthStar Rx Recent Developments
  49. 4.9 Intelicure Lifesciences
  50. 4.9.1 Intelicure Lifesciences Company Information
  51. 4.9.2 Intelicure Lifesciences Business Overview
  52. 4.9.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
  54. 4.9.5 Intelicure Lifesciences Recent Developments
  55. 4.10 EUGIA PHARMA INC
  56. 4.10.1 EUGIA PHARMA INC Company Information
  57. 4.10.2 EUGIA PHARMA INC Business Overview
  58. 4.10.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
  60. 4.10.5 EUGIA PHARMA INC Recent Developments
  61. 4.11 ACS DOBFAR SPA
  62. 4.11.1 ACS DOBFAR SPA Company Information
  63. 4.11.2 ACS DOBFAR SPA Business Overview
  64. 4.11.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
  66. 4.11.5 ACS DOBFAR SPA Recent Developments
5 Global Ertapenem Sodium for Injection Market Scenario by Region
  1. 5.1 Global Ertapenem Sodium for Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Ertapenem Sodium for Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Ertapenem Sodium for Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Ertapenem Sodium for Injection Sales by Region: 2027-2032
  5. 5.3 Global Ertapenem Sodium for Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Ertapenem Sodium for Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Ertapenem Sodium for Injection Revenue by Region: 2027-2032
  8. 5.4 North America Ertapenem Sodium for Injection Market Facts & Figures by Country
  9. 5.4.1 North America Ertapenem Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Ertapenem Sodium for Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Ertapenem Sodium for Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Ertapenem Sodium for Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Ertapenem Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Ertapenem Sodium for Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Ertapenem Sodium for Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Ertapenem Sodium for Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Ertapenem Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Ertapenem Sodium for Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Ertapenem Sodium for Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Ertapenem Sodium for Injection Market Facts & Figures by Country
  41. 5.7.1 South America Ertapenem Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Ertapenem Sodium for Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Ertapenem Sodium for Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Ertapenem Sodium for Injection Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Ertapenem Sodium for Injection Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Ertapenem Sodium for Injection Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Ertapenem Sodium for Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Ertapenem Sodium for Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Ertapenem Sodium for Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Ertapenem Sodium for Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Ertapenem Sodium for Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Ertapenem Sodium for Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Ertapenem Sodium for Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Ertapenem Sodium for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Ertapenem Sodium for Injection Value Chain Analysis
  2. 8.1.1 Ertapenem Sodium for Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Ertapenem Sodium for Injection Production Mode & Process
  5. 8.2 Ertapenem Sodium for Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Ertapenem Sodium for Injection Distributors
  8. 8.2.3 Ertapenem Sodium for Injection Customers
9 Global Ertapenem Sodium for Injection Analyzing Market Dynamics
  1. 9.1 Ertapenem Sodium for Injection Industry Trends
  2. 9.2 Ertapenem Sodium for Injection Industry Drivers
  3. 9.3 Ertapenem Sodium for Injection Industry Opportunities and Challenges
  4. 9.4 Ertapenem Sodium for Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst